The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
Open accessAbstract
Patients with chronic kidney disease (CKD) exhibit an elevated cardiovascular risk manifesting as coronary artery disease, heart failure, arrhythmias, and sudden cardiac death. Although the incidence and prevalence of cardiovascular events is already significantly higher in patients with early CKD stages (CKD stages 1–3) compared with the general population, patients with advanced CKD stages (CKD stages 4–5) exhibit a markedly elevated risk. Cardiovascular rather than end-stage kidney disease (CKD stage 5) is the leading cause of death in this high-risk population. CKD causes a systemic, chronic proinflammatory state contributing to vascular and myocardial remodeling processes resulting in atherosclerotic lesions, vascular calcification, and vascular senescence as well as myocardial fibrosis and calcification of cardiac valves. In this respect, CKD mimics an accelerated aging of the cardiovascular system. This overview article summarizes the current understanding and clinical consequences of cardiovascular disease in CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Self-citationAngiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Dapagliflozin in Patients with Chronic Kidney Disease
Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618
Cardiovascular and renal outcomes with empagliflozin in heart failure
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022190 · Cited by 5,206
Self-citationDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
Mack, M. J., Leon, M. B., Thourani, V. H., Makkar, R., Kodali, S. K., Russo, M., Kapadia, S. R., Malaisrie, S. C., Cohen, D. J., Pibarot, P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814052 · Cited by 4,847
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, F. D. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,030
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00365.x · Cited by 3,946
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
Popma, J. J., Deeb, G. M., Yakubov, S. J., Mumtaz, M., Gada, H., O’Hair, D., Bajwa, T., Heiser, J. C., Merhi, W., Kleiman, N. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1816885 · Cited by 3,674
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806640 · Cited by 3,017
Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H., Corrado, D., Cox, M. G. P. J., Daubert, J. P., et al. (2010) · Circulation · doi:10.1161/circulationaha.108.840827 · Cited by 2,676
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563
Self-citationGoodman, W. G., Goldin, J., Kuizon, B. D., Yoon, C., Gales, B., Sider, D., Wang, Y., Chung, J., Emerick, A., Greaser, L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422003 · Cited by 2,509
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
Levey, A. S., de Jong, P. E., Coresh, J., El Nahas, M., Astor, B. C., Matsushita, K., Gansevoort, R. T., Kasiske, B. L., & Eckardt, K.-U. (2011) · Kidney International · doi:10.1038/ki.2010.483 · Cited by 2,345
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
Boudoulas, K. D., Borer, J. S., & Boudoulas, H. (2015) · Cardiology · doi:10.1159/000435947 · Cited by 1,938
Plasma aldosterone regulation in anephric man
Walker, W. G., & Cooke, C. R. (1973) · Kidney International · doi:10.1038/ki.1973.1 · Cited by 1,841
Chronic Kidney Disease and Mortality Risk: A Systematic Review
Tonelli, M., Wiebe, N., Culleton, B., House, A., Rabbat, C., Fok, M., McAlister, F., & Garg, A. X. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101085 · Cited by 1,658
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Ix, J. H., Knoll, G. A., Muntner, P., Pecoits-Filho, R., Sarnak, M. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.11.003 · Cited by 1,452
Packer, M., Poole-Wilson, P. A., Armstrong, P. W., Cleland, J. G. F., Horowitz, J. D., Massie, B. M., Rydén, L., Thygesen, K., & Uretsky, B. F. (1999) · Circulation · doi:10.1161/01.cir.100.23.2312 · Cited by 1,244
Evolving importance of kidney disease: from subspecialty to global health burden
Eckardt, K.-U., Coresh, J., Devuyst, O., Johnson, R. J., Köttgen, A., Levey, A. S., & Levin, A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60439-0 · Cited by 1,159
Chapter 1: Definition and classification of CKD
(2013) · Kidney International Supplements · doi:10.1038/kisup.2012.64 · Cited by 1,110
Böhm, M., Swedberg, K., Komajda, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61259-7 · Cited by 1,099
Self-citationvan der Velde, M., the Chronic Kidney Disease Prognosis Consortium, Matsushita, K., Coresh, J., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., & Gansevoort, R. T. (2011) · Kidney International · doi:10.1038/ki.2010.536 · Cited by 1,082
Arterial stiffening and vascular calcifications in end‐stage renal disease
Guérin, A. P., London, G. M., Marchais, S. J., & Metivier, F. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.7.1014 · Cited by 1,003
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Verma, S., & McMurray, J. J. V. (2018) · Diabetologia · doi:10.1007/s00125-018-4670-7 · Cited by 999
Arrhythmogenic right ventricular cardiomyopathy
Basso, C., Corrado, D., Marcus, F. I., Nava, A., & Thiene, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60256-7 · Cited by 931
Structural and Functional Changes With the Aging Kidney
Denic, A., Glassock, R. J., & Rule, A. D. (2016) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2015.08.004 · Cited by 819
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease
Thomas, M. C., Cooper, M. E., & Zimmet, P. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.173 · Cited by 742
Ärnlöv, J., Evans, J. C., Meigs, J. B., Wang, T. J., Fox, C. S., Levy, D., Benjamin, E. J., D’Agostino, R. B., & Vasan, R. S. (2005) · Circulation · doi:10.1161/circulationaha.105.538132 · Cited by 736
Bakris, G. L., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.10081 · Cited by 708
Cause of Death in Patients with Reduced Kidney Function
Thompson, S., James, M., Wiebe, N., Hemmelgarn, B., Manns, B., Klarenbach, S., & Tonelli, M. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070714 · Cited by 658
Pitt, B., Kober, L., Ponikowski, P., Gheorghiade, M., Filippatos, G., Krum, H., Nowack, C., Kolkhof, P., Kim, S.-Y., & Zannad, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht187 · Cited by 591
Classical Renin‐Angiotensin System in Kidney Physiology
Sparks, M. A., Crowley, S. D., Gurley, S. B., Mirotsou, M., & Coffman, T. M. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130040 · Cited by 521
Management of coronary disease in patients with advanced kidney disease
Bangalore, S., Maron, D. J., O’Brien, S. M., Fleg, J. L., Kretov, E. I., Briguori, C., Kaul, U., Reynolds, H. R., Mazurek, T., Sidhu, M. S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915925 · Cited by 499
Siontis, G. C. M., Overtchouk, P., Cahill, T. J., Modine, T., Prendergast, B., Praz, F., Pilgrim, T., Petrinic, T., Nikolakopoulou, A., Salanti, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz275 · Cited by 474
Zoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
Self-citationEpidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
Ortiz, A., Covic, A., Fliser, D., Fouque, D., Goldsmith, D., Kanbay, M., Mallamaci, F., Massy, Z. A., Rossignol, P., Vanholder, R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60384-6 · Cited by 435
Self-citationChronic kidney disease management in the United Kingdom: NEOERICA project results
Stevens, P. E., O'Donoghue, D. J., de Lusignan, S., Van Vlymen, J., Klebe, B., Middleton, R., Hague, N., New, J., & Farmer, C. K. T. (2007) · Kidney International · doi:10.1038/sj.ki.5002273 · Cited by 434
Characteristics of sudden death in hemodialysis patients
Bleyer, A. J., Hartman, J., Brannon, P. C., Reeves-Daniel, A., Satko, S. G., & Russell, G. (2006) · Kidney International · doi:10.1038/sj.ki.5000446 · Cited by 397
The Framingham Predictive Instrument in Chronic Kidney Disease
Weiner, D. E., Tighiouart, H., Elsayed, E. F., Griffith, J. L., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.037 · Cited by 380
Palmer, S. C., Craig, J. C., Navaneethan, S. D., Tonelli, M., Pellegrini, F., & Strippoli, G. F. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-4-201208210-00007 · Cited by 359
Left Ventricular Mass in Chronic Kidney Disease and ESRD
Glassock, R. J., Pecoits-Filho, R., & Barberato, S. H. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04860709 · Cited by 352
Sudden and cardiac death rates in hemodialysis patients
Bleyer, A. J., Russell, G. B., & Satko, S. G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00391.x · Cited by 345
Bright, R. (1840) · PubMed · Cited by 332
Chronic kidney disease in the elderly: evaluation and management
Mallappallil, M., Friedman, E. A., Delano, B. G., McFarlane, S. I., & Salifu, M. O. (2014) · Clinical Practice · doi:10.2217/cpr.14.46 · Cited by 298
Ridker, P. M., MacFadyen, J. G., Glynn, R. J., Koenig, W., Libby, P., Everett, B. M., Lefkowitz, M., Thuren, T., & Cornel, J. H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.490 · Cited by 297
Uremic Toxicity: Present State of the Art
Vanholder, R., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., Dedeyn, P. P., Deppisch, R., Descamps-Latscha, B., Henle, T., et al. (2001) · The International Journal of Artificial Organs · doi:10.1177/039139880102401004 · Cited by 281
Packer, M., & Miller, A. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00358-6 · Cited by 278
Lipid management in patients with chronic kidney disease
Ferro, C. J., Mark, P. B., Kanbay, M., Sarafidis, P., Heine, G. H., Rossignol, P., Massy, Z. A., Mallamaci, F., Valdivielso, J. M., Malyszko, J., et al. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0072-9 · Cited by 273
Influence of arterial pulse and reflected waves on blood pressure and cardiac function
London, G. M., & Guerin, A. P. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70313-3 · Cited by 256
Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis
Major, R. W., Cheng, M. R. I., Grant, R. A., Shantikumar, S., Xu, G., Oozeerally, I., Brunskill, N. J., & Gray, L. J. (2018) · PLOS ONE · doi:10.1371/journal.pone.0192895 · Cited by 252
Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment
Di Lullo, L., Gorini, A., Russo, D., Santoboni, A., & Ronco, C. (2015) · Cardiorenal Medicine · doi:10.1159/000435838 · Cited by 235
Matsumoto, Y., Mori, Y., Kageyama, S., Arihara, K., Sugiyama, T., Ohmura, H., Yakushigawa, T., Sugiyama, H., Shimada, Y., Nojima, Y., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.056 · Cited by 223
Palmer, S. C., Di Micco, L., Razavian, M., Craig, J. C., Perkovic, V., Pellegrini, F., Copetti, M., Graziano, G., Tognoni, G., Jardine, M., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-6-201203200-00007 · Cited by 204
Electrolyte and Acid-Base Disorders in Chronic Kidney Disease and End-Stage Kidney Failure
Dhondup, T., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452725 · Cited by 198
Herzog, C. A., Ma, J. Z., & Collins, A. J. (2002) · Circulation · doi:10.1161/hc1102.100075 · Cited by 191
Agharazii, M., St-Louis, R., Gautier-Bastien, A., Ung, R.-V., Mokas, S., Larivière, R., & Richard, D. E. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpu225 · Cited by 180
De Vriese, A. S., Caluwé, R., Pyfferoen, L., De Bacquer, D., De Boeck, K., Delanote, J., De Surgeloose, D., Van Hoenacker, P., Van Vlem, B., & Verbeke, F. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019060579 · Cited by 177
Effects of Beta-Adrenergic Antagonists in Patients With Chronic Kidney Disease
Badve, S. V., Roberts, M. A., Hawley, C. M., Cass, A., Garg, A. X., Krum, H., Tonkin, A., & Perkovic, V. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.041 · Cited by 175
Sudden Cardiac Death in Hemodialysis Patients: An In-Depth Review
Green, D., Roberts, P. R., New, D. I., & Kalra, P. A. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.02.376 · Cited by 166
Amdur, R. L., Feldman, H. I., Dominic, E. A., Anderson, A. H., Beddhu, S., Rahman, M., Wolf, M., Reilly, M., Ojo, A., Townsend, R. R., et al. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.09.012 · Cited by 163
Heart Failure in Patients with Chronic Kidney Disease: A Systematic Integrative Review
Segall, L., Nistor, I., & Covic, A. (2014) · BioMed Research International · doi:10.1155/2014/937398 · Cited by 158
Sakaguchi, Y., Hamano, T., Obi, Y., Monden, C., Oka, T., Yamaguchi, S., Matsui, I., Hashimoto, N., Matsumoto, A., Shimada, K., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018111150 · Cited by 157
Does Uremia Cause Vascular Dysfunction
Brunet, P., Gondouin, B., Duval-Sabatier, A., Dou, L., Cérini, C., Dignat‐George, F., Jourde‐Chiche, N., Argilés, À., & Burtey, S. (2011) · Kidney & Blood Pressure Research · doi:10.1159/000327131 · Cited by 152
Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction
Fujii, H., Goto, S., & Fukagawa, M. (2018) · Toxins · doi:10.3390/toxins10050202 · Cited by 146
Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation
Brandenburg, V. M., Reinartz, S. D., Kaesler, N., Krüger, T., Dirrichs, T., Kramann, R., Peeters, F. E. C. M., Floege, J., Keszei, A. P., Marx, N., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.027011 · Cited by 144
Self-citationMagnesium Counteracts Vascular Calcification: Passive Interference or Active Modulation?
ter Braake, A. D., Shanahan, C. M., & de Baaij, J. H. F. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309182 · Cited by 128
Uremic Cardiomyopathy: An Underdiagnosed Disease
Alhaj, E. K., Alhaj, N., Rahman, I. U., Niazi, T., Berkowitz, R. L., & Klapholz, M. (2013) · Congestive Heart Failure · doi:10.1111/chf.12030 · Cited by 124
Percutaneous tricuspid valve therapies: the new frontier
Taramasso, M., Pozzoli, A., Guidotti, A., Nietlispach, F., Inderbitzin, D., Benussi, S., Alfieri, O., & Maisano, F. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv766 · Cited by 124
HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype
Shroff, R. C., Speer, T., Colin, S., Charakida, M., Zewinger, S., Staels, B., Chinetti, G., Hettrich, I., Rohrer, L., O’Neill, F., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111212 · Cited by 123
Self-citationSymmetric dimethylarginine, high-density lipoproteins and cardiovascular disease
Zewinger, S., Kleber, M. E., Rohrer, L., Lehmann, M., Triem, S., Jennings, R. T., Petrakis, I., Dressel, A., Lepper, P. M., Scharnagl, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx118 · Cited by 118
Self-citationValvular heart disease and calcification in CKD: more common than appreciated
Ureña, P., D’Marco, L., Raggi, P., García–Moll, X., Brandenburg, V. M., Mazzaferro, S., Lieber, A., Guirado, L., & Bover, J. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz133 · Cited by 115
Edner, M., Benson, L., Dahlström, U., & Lund, L. H. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv268 · Cited by 113
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.76 · Cited by 113
Charytan, D. M., Himmelfarb, J., Ikizler, T. A., Raj, D. S., Hsu, J. Y., Landis, J. R., Anderson, A. H., Hung, A. M., Mehrotra, R., Sharma, S., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.08.034 · Cited by 112
Riddle, M. C. (2010) · Circulation · doi:10.1161/circulationaha.110.960138 · Cited by 109
Lan, N. S. R., Fegan, P. G., Yeap, B. B., & Dwivedi, G. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12505 · Cited by 100
PGE2, Kidney Disease, and Cardiovascular Risk
Nasrallah, R., Hassouneh, R., & Hébert, R. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050528 · Cited by 98
Relationship between Magnesium and Clinical Biomarkers on Inhibition of Vascular Calcification
Salem, S., Bruck, H., Bahlmann, F. H., Peter, M. E., Passlick‐Deetjen, J., Kretschmer, A., Steppan, S., Volsek, M., Kribben, A., Nierhaus, M., et al. (2011) · American Journal of Nephrology · doi:10.1159/000334742 · Cited by 96
Self-citationHammer, F., Malzahn, U., Donhauser, J., Betz, C., Schneider, M. P., Grupp, C., Pollak, N., Störk, S., Wanner, C., Krane, V., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.025 · Cited by 96
Sudden cardiac death in dialysis patients: different causes and management strategies
Genovesi, S., Boriani, G., Covic, A. C., Vernooij, R. W. M., Combe, C., Burlacu, A., Davenport, A., Kanbay, M., Kirmizis, D. A., Schneditz, D., et al. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz182 · Cited by 92
Washam, J. B., Herzog, C. A., Beitelshees, A. L., Cohen, M. G., Henry, T. D., Kapur, N. K., Mega, J. L., Menon, V., Page, R. L., II, & Newby, L. K. (2015) · Circulation · doi:10.1161/cir.0000000000000183 · Cited by 86
Health status after invasive or conservative care in coronary and advanced kidney disease
Spertus, J. A., Jones, P. G., Maron, D. J., Mark, D. B., O’Brien, S. M., Fleg, J. L., Reynolds, H. R., Stone, G. W., Sidhu, M. S., Chaitman, B. R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916374 · Cited by 84
Wang, Z., Jiang, A., Wei, F., & Chen, H. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0747-y · Cited by 82
Recent progress in the treatment of vascular calcification
O'Neill, W. C., & Lomashvili, K. A. (2010) · Kidney International · doi:10.1038/ki.2010.334 · Cited by 80
Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease
Gauthier-Bastien, A., Ung, R., Larivière, R., Mac‐Way, F., Lebel, M., & Agharazii, M. (2013) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.804541 · Cited by 75
Mulè, G., Castiglia, A., Cusumano, C., Scaduto, E., Geraci, G., Altieri, D. C., Natale, E. D., Cacciatore, O., Cerasola, G., & Cottone, S. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_85 · Cited by 75
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
Kotecha, D., Gill, S. K., Flather, M. D., Holmes, J., Packer, M., Rosano, G., Böhm, M., McMurray, J. J. V., Wikstrand, J., Anker, S. D., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.059 · Cited by 71
Self-citationPolycystins, ADPKD, and Cardiovascular Disease
Kuo, I. Y., & Chapman, A. B. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.12.007 · Cited by 71
Voors, A. A., van Veldhuisen, D. J., Robertson, M., Ford, I., BORER, J. S., Böhm, M., Michel Komajda, N., Swedberg, K. B., & Tavazzi, L. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.59 · Cited by 58
Self-citationChronic kidney disease measures and the risk of abdominal aortic aneurysm
Matsushita, K., Kwak, L., Ballew, S. H., Grams, M. E., Selvin, E., Folsom, A. R., Coresh, J., & Tang, W. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.08.043 · Cited by 57
Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease
Patel, K., Shah, S. Y., Arrigain, S., Jolly, S. E., Schold, J. D., Navaneethan, S. D., Griffin, B. P., Nally, J. V., & Desai, M. Y. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.009980 · Cited by 57
Maini, R., Wong, D. B., Addison, D., Chiang, E., Weisbord, S. D., & Jneid, H. M. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018070674 · Cited by 54
Buglioni, A., & Burnett, J. C. J. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.10.027 · Cited by 51
Shobeiri, N., Pang, J. J., Adams, M. A., & Holden, R. M. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835b15bb · Cited by 50
Magnesium in CKD: more than a calcification inhibitor?
Floege, J. (2014) · Journal of Nephrology · doi:10.1007/s40620-014-0140-6 · Cited by 45
Self-citationAlamir, M. A., Radulescu, V., Goyfman, M., Mohler, E. R., Gao, Y. L., & Budoff, M. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.013 · Cited by 44
Advanced chronic kidney disease: Relationship to outcomes post‐TAVR, a meta‐analysis
Makki, N. M., & Lilly, S. M. (2018) · Clinical Cardiology · doi:10.1002/clc.22993 · Cited by 38
Biomarkers in cardiorenal syndromes
Tan, K. M. L., & Sethi, S. K. (2014) · Translational research · doi:10.1016/j.trsl.2014.04.011 · Cited by 37
Blood pressure targets and kidney and cardiovascular disease
Roehm, B. A., & Weiner, D. E. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000492 · Cited by 34
Coronary artery calcification predicts risk of CVD in patients with CKD
Raggi, P. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.61 · Cited by 33
Kielstein, J. T., Veldink, H., Martens‐Lobenhoffer, J., Haller, H. G., Perthel, R., Lovric, S., Lichtinghagen, R., Kliem, V., & Bode‐Böger, S. M. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00640.2010 · Cited by 32
Briet, M. B., Barhoumi, T., Mian, M. O. R., Sierra, C., Boutouyrie, P., Davidman, M., Bercovitch, D. D., Nessim, S. J., Frisch, G., Paradis, P., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000128 · Cited by 32
Timing of sudden death relative to the hemodialysis procedure
Perl, J. M., & Chan, C. T. (2006) · Nature Reviews Nephrology · doi:10.1038/ncpneph0345 · Cited by 22
Heart failure with a normal left ventricular ejection fraction: diastolic heart failure.
Little, W. C. (2008) · PubMed Central · Cited by 18
Ma, I. W. Y., Guo, M., Muruve, D. A., Benediktsson, H., & Naugler, C. T. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0991-5 · Cited by 17
Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients
Cheema, A., Singh, T., Kanwar, M. K., Chilukuri, K., Maria, V., Saleem, F., Johnson, K. M., Frank, J. J., Pires, L. A., & Hassan, S. A. (2010) · Cardiology Research and Practice · doi:10.4061/2010/989261 · Cited by 16
Onal, E. M., Sag, A. A., Sal, O., Yerlikaya, A., Afşar, B., & Kanbay, M. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2016.1246565 · Cited by 12
Negotiating renal dysfunction when treating patients with heart failure
Carubelli, V., Metra, M., & Lund, L. H. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1422178 · Cited by 11
Cited by
Development and validation of the American Heart Association’s PREVENT equations
Khan, S. S., Matsushita, K., Sang, Y., Ballew, S. H., Grams, M. E., Surapaneni, A., Blaha, M. J., Carson, A. P., Chang, A. R., Ciemins, E., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067626 · Cited by 1,234
Epidemiology of haemodialysis outcomes
Bello, A. K., Okpechi, I. G., Osman, M. A., Cho, Y., Htay, H., Jha, V., Wainstein, M., & Johnson, D. W. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00542-7 · Cited by 631
The cardio-renal-metabolic connection: a review of the evidence
Marassi, M., & Fadini, G. P. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01937-x · Cited by 386
Filippatos, G., Anker, S. D., Agarwal, R., Ruilope, L. M., Rossing, P., Bakris, G. L., Tasto, C., Joseph, A., Kolkhof, P., Lage, A., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057983 · Cited by 299
Pratley, R. E., Tuttle, K. R., Rossing, P., Rasmussen, S., Perkovic, V., Nielsen, O. W., Mann, J. F. E., MacIsaac, R. J., Kosiborod, M. N., Kamenov, Z., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.08.004 · Cited by 132
Metadata
- Authors
- Jankowski, J., Floege, J., Fliser, D., Böhm, M., & Marx, N.
- Venue
- Circulation
- Published
- 2021-03-16
- Volume
- 143
- Issue
- 11
- Pages
- 1157-1172
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2904356389
- Cited by
- 1,904
- References
- 134
- FWCI
- 160.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.